Report Detail

Medical Industry Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Insights, Forecast to 2028

  • RnM4439513
  • |
  • 12 May, 2022
  • |
  • Global
  • |
  • 114 Pages
  • |
  • QYResearch
  • |
  • Medical Industry

Summary:

Market Analysis and Insights: Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market
The global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Peripheral Parenteral Nutrition (PPN) accounting for % of the Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market size is valued at US$ million in 2021, while the North America and Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market.
Impact of Covid-19 Outbreak
This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.
Segmental Analysis
The report has been segmented into product and application segments. The researchers have documented all the products present today in the Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.
Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Breakdown Data by Type
Peripheral Parenteral Nutrition (PPN)
Total Parenteral Nutrition (TPN)
Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Breakdown Data by Application
Hospital
Home
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape
This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:
Eurofarma
Corporacion De Laboratorios Farmaceuticos
Baxter International Inc.
Kelun Pharma
B. Braun
Fresenius
Teva Pharmaceutical Industries
Pfizer (Hospira)
Ostuka Pharmaceutical
Laboratorios Biogalenic
Laboratorios Finlay
Grifols International
Fresenius Kabi
Sichuan Kelun Pharmaceutical
Frequently Asked Questions
What factors will challenge the Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market growth?
Which end-use segment will expand at the fastest CAGR in the Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market?
Which are the emerging players in the Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market?
How concentrated is the Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market?
Which factors are positively contributing to the Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market growth?
Which are the novel product innovations in the Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market?
Which product segment will emerge as the most lucrative in the Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market?
Which factors are increasing the competition in the Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market?
Which are the strategic measures taken by the Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market in the coming years?


Table of Contents

    1 Report Business Overview

    • 1.1 Study Scope
    • 1.2 Market Analysis by Type
      • 1.2.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
      • 1.2.2 Peripheral Parenteral Nutrition (PPN)
      • 1.2.3 Total Parenteral Nutrition (TPN)
    • 1.3 Market by Application
      • 1.3.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
      • 1.3.2 Hospital
      • 1.3.3 Home
    • 1.4 Study Objectives
    • 1.5 Years Considered

    2 Global Growth Trends

    • 2.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Perspective (2017-2028)
    • 2.2 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Growth Trends by Region
      • 2.2.1 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region: 2017 VS 2021 VS 2028
      • 2.2.2 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Historic Market Size by Region (2017-2022)
      • 2.2.3 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Region (2023-2028)
    • 2.3 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Dynamics
      • 2.3.1 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Industry Trends
      • 2.3.2 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Drivers
      • 2.3.3 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Challenges
      • 2.3.4 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Restraints

    3 Competition Landscape by Key Players

    • 3.1 Global Top Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Players by Revenue
      • 3.1.1 Global Top Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Players by Revenue (2017-2022)
      • 3.1.2 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue Market Share by Players (2017-2022)
    • 3.2 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.3 Players Covered: Ranking by Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue
    • 3.4 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Concentration Ratio
      • 3.4.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Concentration Ratio (CR5 and HHI)
      • 3.4.2 Global Top 10 and Top 5 Companies by Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Revenue in 2021
    • 3.5 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Key Players Head office and Area Served
    • 3.6 Key Players Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Product Solution and Service
    • 3.7 Date of Enter into Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market
    • 3.8 Mergers & Acquisitions, Expansion Plans

    4 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Breakdown Data by Type

    • 4.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Historic Market Size by Type (2017-2022)
    • 4.2 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Type (2023-2028)

    5 Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Breakdown Data by Application

    • 5.1 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Historic Market Size by Application (2017-2022)
    • 5.2 Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Forecasted Market Size by Application (2023-2028)

    6 North America

    • 6.1 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2017-2028)
    • 6.2 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Type
      • 6.2.1 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Type (2017-2022)
      • 6.2.2 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Type (2023-2028)
      • 6.2.3 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Type (2017-2028)
    • 6.3 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Application
      • 6.3.1 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Application (2017-2022)
      • 6.3.2 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Application (2023-2028)
      • 6.3.3 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Application (2017-2028)
    • 6.4 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country
      • 6.4.1 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2017-2022)
      • 6.4.2 North America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2023-2028)
      • 6.4.3 United States
      • 6.4.4 Canada

    7 Europe

    • 7.1 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2017-2028)
    • 7.2 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Type
      • 7.2.1 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Type (2017-2022)
      • 7.2.2 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Type (2023-2028)
      • 7.2.3 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Type (2017-2028)
    • 7.3 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Application
      • 7.3.1 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Application (2017-2022)
      • 7.3.2 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Application (2023-2028)
      • 7.3.3 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Application (2017-2028)
    • 7.4 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country
      • 7.4.1 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2017-2022)
      • 7.4.2 Europe Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2023-2028)
      • 7.4.3 Germany
      • 7.4.4 France
      • 7.4.5 U.K.
      • 7.4.6 Italy
      • 7.4.7 Russia
      • 7.4.8 Nordic Countries

    8 Asia-Pacific

    • 8.1 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2017-2028)
    • 8.2 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Type
      • 8.2.1 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Type (2017-2022)
      • 8.2.2 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Type (2023-2028)
      • 8.2.3 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Type (2017-2028)
    • 8.3 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Application
      • 8.3.1 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Application (2017-2022)
      • 8.3.2 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Application (2023-2028)
      • 8.3.3 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Application (2017-2028)
    • 8.4 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region
      • 8.4.1 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region (2017-2022)
      • 8.4.2 Asia-Pacific Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Region (2023-2028)
      • 8.4.3 China
      • 8.4.4 Japan
      • 8.4.5 South Korea
      • 8.4.6 Southeast Asia
      • 8.4.7 India
      • 8.4.8 Australia

    9 Latin America

    • 9.1 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2017-2028)
    • 9.2 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Type
      • 9.2.1 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Type (2017-2022)
      • 9.2.2 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Type (2023-2028)
      • 9.2.3 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Type (2017-2028)
    • 9.3 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Application
      • 9.3.1 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Application (2017-2022)
      • 9.3.2 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Application (2023-2028)
      • 9.3.3 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Application (2017-2028)
    • 9.4 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country
      • 9.4.1 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2017-2022)
      • 9.4.2 Latin America Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2023-2028)
      • 9.4.3 Mexico
      • 9.4.4 Brazil

    10 Middle East & Africa

    • 10.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size (2017-2028)
    • 10.2 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Type
      • 10.2.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Type (2017-2022)
      • 10.2.2 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Type (2023-2028)
      • 10.2.3 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Type (2017-2028)
    • 10.3 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Application
      • 10.3.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Application (2017-2022)
      • 10.3.2 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Application (2023-2028)
      • 10.3.3 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Share by Application (2017-2028)
    • 10.4 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country
      • 10.4.1 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2017-2022)
      • 10.4.2 Middle East & Africa Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Size by Country (2023-2028)
      • 10.4.3 Turkey
      • 10.4.4 Saudi Arabia
      • 10.4.5 UAE

    11 Key Players Profiles

    • 11.1 Eurofarma
      • 11.1.1 Eurofarma Company Details
      • 11.1.2 Eurofarma Business Overview
      • 11.1.3 Eurofarma Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
      • 11.1.4 Eurofarma Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
      • 11.1.5 Eurofarma Recent Developments
    • 11.2 Corporacion De Laboratorios Farmaceuticos
      • 11.2.1 Corporacion De Laboratorios Farmaceuticos Company Details
      • 11.2.2 Corporacion De Laboratorios Farmaceuticos Business Overview
      • 11.2.3 Corporacion De Laboratorios Farmaceuticos Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
      • 11.2.4 Corporacion De Laboratorios Farmaceuticos Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
      • 11.2.5 Corporacion De Laboratorios Farmaceuticos Recent Developments
    • 11.3 Baxter International Inc.
      • 11.3.1 Baxter International Inc. Company Details
      • 11.3.2 Baxter International Inc. Business Overview
      • 11.3.3 Baxter International Inc. Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
      • 11.3.4 Baxter International Inc. Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
      • 11.3.5 Baxter International Inc. Recent Developments
    • 11.4 Kelun Pharma
      • 11.4.1 Kelun Pharma Company Details
      • 11.4.2 Kelun Pharma Business Overview
      • 11.4.3 Kelun Pharma Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
      • 11.4.4 Kelun Pharma Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
      • 11.4.5 Kelun Pharma Recent Developments
    • 11.5 B. Braun
      • 11.5.1 B. Braun Company Details
      • 11.5.2 B. Braun Business Overview
      • 11.5.3 B. Braun Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
      • 11.5.4 B. Braun Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
      • 11.5.5 B. Braun Recent Developments
    • 11.6 Fresenius
      • 11.6.1 Fresenius Company Details
      • 11.6.2 Fresenius Business Overview
      • 11.6.3 Fresenius Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
      • 11.6.4 Fresenius Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
      • 11.6.5 Fresenius Recent Developments
    • 11.7 Teva Pharmaceutical Industries
      • 11.7.1 Teva Pharmaceutical Industries Company Details
      • 11.7.2 Teva Pharmaceutical Industries Business Overview
      • 11.7.3 Teva Pharmaceutical Industries Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
      • 11.7.4 Teva Pharmaceutical Industries Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
      • 11.7.5 Teva Pharmaceutical Industries Recent Developments
    • 11.8 Pfizer (Hospira)
      • 11.8.1 Pfizer (Hospira) Company Details
      • 11.8.2 Pfizer (Hospira) Business Overview
      • 11.8.3 Pfizer (Hospira) Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
      • 11.8.4 Pfizer (Hospira) Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
      • 11.8.5 Pfizer (Hospira) Recent Developments
    • 11.9 Ostuka Pharmaceutical
      • 11.9.1 Ostuka Pharmaceutical Company Details
      • 11.9.2 Ostuka Pharmaceutical Business Overview
      • 11.9.3 Ostuka Pharmaceutical Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
      • 11.9.4 Ostuka Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
      • 11.9.5 Ostuka Pharmaceutical Recent Developments
    • 11.10 Laboratorios Biogalenic
      • 11.10.1 Laboratorios Biogalenic Company Details
      • 11.10.2 Laboratorios Biogalenic Business Overview
      • 11.10.3 Laboratorios Biogalenic Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
      • 11.10.4 Laboratorios Biogalenic Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
      • 11.10.5 Laboratorios Biogalenic Recent Developments
    • 11.11 Laboratorios Finlay
      • 11.11.1 Laboratorios Finlay Company Details
      • 11.11.2 Laboratorios Finlay Business Overview
      • 11.11.3 Laboratorios Finlay Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
      • 11.11.4 Laboratorios Finlay Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
      • 11.11.5 Laboratorios Finlay Recent Developments
    • 11.12 Grifols International
      • 11.12.1 Grifols International Company Details
      • 11.12.2 Grifols International Business Overview
      • 11.12.3 Grifols International Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
      • 11.12.4 Grifols International Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
      • 11.12.5 Grifols International Recent Developments
    • 11.13 Fresenius Kabi
      • 11.13.1 Fresenius Kabi Company Details
      • 11.13.2 Fresenius Kabi Business Overview
      • 11.13.3 Fresenius Kabi Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
      • 11.13.4 Fresenius Kabi Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
      • 11.13.5 Fresenius Kabi Recent Developments
    • 11.14 Sichuan Kelun Pharmaceutical
      • 11.14.1 Sichuan Kelun Pharmaceutical Company Details
      • 11.14.2 Sichuan Kelun Pharmaceutical Business Overview
      • 11.14.3 Sichuan Kelun Pharmaceutical Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Introduction
      • 11.14.4 Sichuan Kelun Pharmaceutical Revenue in Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Business (2017-2022)
      • 11.14.5 Sichuan Kelun Pharmaceutical Recent Developments

    12 Analyst's Viewpoints/Conclusions

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
        • 13.1.2 Data Source
      • 13.2 Author Details

      Summary:
      Get latest Market Research Reports on Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN). Industry analysis & Market Report on Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) is a syndicated market report, published as Global Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) Market Insights, Forecast to 2028. It is complete Research Study and Industry Analysis of Peripheral Parenteral Nutrition (PPN) and Total Parenteral Nutrition (TPN) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,350.00
      $8,700.00
      3,606.15
      7,212.30
      4,171.65
      8,343.30
      589,381.50
      1,178,763.00
      343,563.00
      687,126.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report